Clarification To Require an Opioid Use Disorder Diagnosis on Claims for OUD Treatment Services Section 1861(s)(2)(HH) of the Act, as amended by section 2005 of the SUPPORT Act, implemented Medicare coverage for opioid use disorder treatment services. Section 1861(jjj)(1) of the Act describes opioid use disorder treatment services as items and services that are furnished by an opioid treatment program for the treatment of opioid use disorder
A rebate reduction request should specify each NDC-11 to which the request applies and if CMS grants a manufacturer's likely to be in shortage rebate reduction request for an NDC-11, CMS proposes in 428.303(b)(3) that the rebate reduction would apply to the entire generic Part D rebatable drug at the NDC-9 level
[394] Additionally, as part of initial and periodic assessment services at 8.12(f)(4), OTPs must designate in the care plan a patient's needs and goals in the areas of harm reduction interventions, education, vocational training, and employment, along with the medical and psychiatric, psychosocial, economic, legal, housing, and other recovery support services that a patient needs and wishes to pursue, which all reflect consideration to various health-related social needs
1571 European doctors start publishing works on healthy properties of the tobacco plant, claiming it can cure a myriad of diseases, from toothache to lockjaw and cancer
CMS may recalculate a rebate amount and provide the manufacturer of a Part B rebatable drug a report with a reconciled rebate amount when: (i) CMS identifies an agency error in the information specified in paragraphs (c) and (d)(1) of this section, including reporting system or coding errors, not later than 3 years from the date of receipt by a manufacturer of a reconciled rebate amount for the applicable calendar quarter
The overpayment must be reported and returned within 60 days after either completion of the investigation or day 180, whichever is earlier